{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2015"],"condition":["Circulating Tumor Cells","Neoplastic Cells, Circulating","Epithelial-Mesenchymal Transition"],"disease":["Circulating Tumor Cells","Neoplastic Cells, Circulating","Epithelial-mesenchymal Transition"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2202184"],"location":["China"],"study_start_month":["11"],"keyword":["Aspirin","Metastatic breast cancer","Metastatic colorectal cancer"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Aspirin on CTCs of Advanced Breast and Colorectal Cancer","description":"The purpose of this study is to determine whether Aspirin could affect the number and subtype of circulating tumor cells of metastatic breast cancer and colorectal cancer.","dates":{"creation":"2015-11-15"},"accession":"2202184","cross_references":{"ClinicalTrials___gov":["NCT02602938"]}}